{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:13:34Z","timestamp":1794071614054,"version":"4.8.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["01A1"],"award-info":[{"award-number":["01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP180748"],"award-info":[{"award-number":["RP180748"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP190672"],"award-info":[{"award-number":["RP190672"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R15GM126475\\u201301A1"],"award-info":[{"award-number":["1R15GM126475\\u201301A1"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["U54MD007605"],"award-info":[{"award-number":["U54MD007605"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.112080","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T06:06:08Z","timestamp":1629785168000},"page":"112080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["Developing nutritional component chrysin as a therapeutic agent: Bioavailability and pharmacokinetics consideration, and ADME mechanisms"],"prefix":"10.1016","volume":"142","author":[{"given":"Song","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyma","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imoh","family":"Etim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112080_bib1","unstructured":"A. Perkin, Berichte der dLuteolin, Part 2, Journal of the Chemical Society, Transactions, 1896. \u3008https:\/\/pubs.rsc.org\/en\/content\/articlepdf\/1896\/ct\/ct8966900799?casa_token=yZhxRQrX-H0AAAAA:Wo3HIAy8yFYSzu7oumF4wFA8EZ1HnlgC0uSEE7lor849a_hhplndYkvTZ23JzDEUb008_caIC7O7\u3009."},{"key":"10.1016\/j.biopha.2021.112080_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116797","article-title":"Chrysin: pharmacological and therapeutic properties","volume":"235","author":"Naz","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2021.112080_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.fct.2013.01.010","article-title":"Bioactive microconstituents and antioxidant properties of wild edible mushrooms from the island of Lesvos, Greece","volume":"55","author":"Kalogeropoulos","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2021.112080_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.phytochem.2017.09.016","article-title":"Chrysin: sources, beneficial pharmacological activities, and molecular mechanism of action","volume":"145","author":"Mani","year":"2018","journal-title":"Phytochemistry"},{"issue":"5","key":"10.1016\/j.biopha.2021.112080_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1469066720963003","article-title":"Detection of flavone C-glycosides in the extracts from the bark of Prunus avium L. and Prunus cerasus L","volume":"26","author":"Beszterda","year":"2020","journal-title":"Eur. J. Mass Spectrom. (Chichester)"},{"key":"10.1016\/j.biopha.2021.112080_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3389\/fphar.2018.01447","article-title":"Moringa oleifera leaf petroleum ether extract inhibits lipogenesis by activating the AMPK signaling pathway","volume":"9","author":"Xie","year":"2018","journal-title":"Front Pharm."},{"issue":"14","key":"10.1016\/j.biopha.2021.112080_bib7","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1055\/s-2007-990248","article-title":"Effect of 7-O-beta-D-glucopyranosylchrysin and its aglycone chrysin isolated from Podocytisus caramanicus on estrogen receptor alpha transcriptional activity","volume":"73","author":"Berthier","year":"2007","journal-title":"Planta Med."},{"issue":"Suppl","key":"10.1016\/j.biopha.2021.112080_bib8","first-page":"46","article-title":"Bioactivity-guided study of Passiflora caerulea L. leaf extracts","volume":"16","author":"El-Askary","year":"2017","journal-title":"Iran. J. Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112080_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acschembio.7b00903","article-title":"Seven year itch: pan-assay interference compounds (PAINS) in 2017-utility and limitations","volume":"13","author":"Baell","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112080_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1559325817711782","article-title":"Protective effects of chrysin against drugs and toxic agents","volume":"15","author":"Samarghandian","year":"2017","journal-title":"Dose Response"},{"key":"10.1016\/j.biopha.2021.112080_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104612","article-title":"Neuroprotective potential of chrysin in Parkinson\u2019s disease: molecular mechanisms and clinical implications","volume":"132","author":"Angelopoulou","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2021.112080_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbi.2019.05.010","article-title":"A comprehensive review on hepatoprotective and nephroprotective activities of chrysin against various drugs and toxic agents","volume":"308","author":"Pingili","year":"2019","journal-title":"Chem. Biol. Inter."},{"issue":"1","key":"10.1016\/j.biopha.2021.112080_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1871525717666190114145137","article-title":"The cardiovascular protective effects of chrysin: a narrative review on experimental researches","volume":"17","author":"Farkhondeh","year":"2019","journal-title":"Cardiovasc Hematol. Agents Med. Chem."},{"key":"10.1016\/j.biopha.2021.112080_bib14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.biopha.2017.06.003","article-title":"An overview on immunoregulatory and anti-inflammatory properties of chrysin and flavonoids substances","volume":"92","author":"Zeinali","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2021.112080_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbi.2019.02.005","article-title":"A20 as a novel target for the anti-neuroinflammatory effect of chrysin via inhibition of NF-kappaB signaling pathway","volume":"79","author":"Li","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2021.112080_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejphar.2016.09.005","article-title":"Neurochemical factors associated with the antidepressant-like effect of flavonoid chrysin in chronically stressed mice","volume":"791","author":"Filho","year":"2016","journal-title":"Eur. J. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2021.112080_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/biom10101374","article-title":"Broad-spectrum preclinical antitumor activity of chrysin: current trends and future perspectives","volume":"10","author":"Moghadam","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.biopha.2021.112080_bib18","first-page":"24","article-title":"Potentiating activities of chrysin in the therapeutic efficacy of 5-fluorouracil in gastric cancer cells","volume":"21","author":"Lee","year":"2021","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2021.112080_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1534735416645184","article-title":"Chrysin increases the therapeutic efficacy of docetaxel and mitigates docetaxel-induced edema","volume":"16","author":"Lim","year":"2017","journal-title":"Integr. Cancer Ther."},{"issue":"6","key":"10.1016\/j.biopha.2021.112080_bib20","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.2042-7158.2012.01470.x","article-title":"Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress","volume":"64","author":"Sultana","year":"2012","journal-title":"J. Pharm. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2021.112080_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00280-005-0053-0","article-title":"A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer","volume":"57","author":"Tobin","year":"2006","journal-title":"Cancer Chemother. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112080_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11010-013-1830-4","article-title":"Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis","volume":"385","author":"Ali","year":"2014","journal-title":"Mol. Cell Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2021.112080_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4062\/biomolther.2015.197","article-title":"Pharmacokinetic interaction of chrysin with caffeine in rats","volume":"24","author":"Noh","year":"2016","journal-title":"Biomol. Ther. (Seoul. )"},{"issue":"10","key":"10.1016\/j.biopha.2021.112080_bib24","doi-asserted-by":"crossref","first-page":"17144","DOI":"10.1002\/jcp.28488","article-title":"Impact of chrysin on the molecular mechanisms underlying diabetic complications","volume":"234","author":"Farkhondeh","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112080_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2125.2001.01317.x","article-title":"Disposition and metabolism of the flavonoid chrysin in normal volunteers","volume":"51","author":"Walle","year":"2001","journal-title":"Br. J. Clin. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2021.112080_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1024\/0300-9831.71.5.293","article-title":"Effects of androstenedione-herbal supplementation on serum sex hormone concentrations in 30- to 59-year-old men","volume":"71","author":"Brown","year":"2001","journal-title":"Int J. Vitam. Nutr. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.112080_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/07315724.2003.10719319","article-title":"Ingestion of a dietary supplement containing dehydroepiandrosterone (DHEA) and androstenedione has minimal effect on immune function in middle-aged men","volume":"22","author":"Kohut","year":"2003","journal-title":"J. Am. Coll. Nutr."},{"issue":"5","key":"10.1016\/j.biopha.2021.112080_bib28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/07315724.2001.10719061","article-title":"Endocrine and lipid responses to chronic androstenediol-herbal supplementation in 30 to 58 year old men","volume":"20","author":"Brown","year":"2001","journal-title":"J. Am. Coll. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2021.112080_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1123\/ijsnem.10.3.340","article-title":"Effects of anabolic precursors on serum testosterone concentrations and adaptations to resistance training in young men","volume":"10","author":"Brown","year":"2000","journal-title":"Int J. Sport Nutr. Exerc Metab."},{"issue":"4","key":"10.1016\/j.biopha.2021.112080_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/109662003772519967","article-title":"Effects of chrysin on urinary testosterone levels in human males","volume":"6","author":"Gambelunghe","year":"2003","journal-title":"J. Med. Food"},{"issue":"1","key":"10.1016\/j.biopha.2021.112080_bib31","doi-asserted-by":"crossref","first-page":"18056","DOI":"10.1038\/s41598-018-37157-7","article-title":"Propolis-based niosomes as oromuco-adhesive films: a randomized clinical trial of a therapeutic drug delivery platform for the treatment of oral recurrent aphthous ulcers","volume":"8","author":"Arafa","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.112080_bib32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2012.02.003","article-title":"Developability assessment of clinical drug products with maximum absorbable doses","volume":"427","author":"Ding","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2021.112080_bib33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/03639045.2019.1576726","article-title":"Chrysin-loaded folate conjugated PF127-F68 mixed micelles with enhanced oral bioavailability and anticancer activity against human breast cancer cells","volume":"45","author":"Baidya","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2021.112080_bib34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic circulation: physiological, pharmacokinetic and clinical implications","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2021.112080_bib35","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3390\/molecules23071702","article-title":"Simultaneous determination of chrysin and tectochrysin from Alpinia oxyphylla fruits by UPLC-MS\/MS and its application to a comparative pharmacokinetic study in normal and dementia rats","volume":"23","author":"Zhao","year":"2018","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biopha.2021.112080_bib36","first-page":"363","article-title":"Ultrastructural analysis of the attachment sites of Escherichia coli to the human spermatozoon after in vitro migration through estrogenic cervical mucus","volume":"34","author":"Sanchez","year":"1989","journal-title":"Int. J. Fertil."},{"issue":"9","key":"10.1016\/j.biopha.2021.112080_bib37","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1021\/acs.molpharmaceut.6b00851","article-title":"Sodium oleate-based nanoemulsion enhances oral absorption of chrysin through inhibition of UGT-mediated metabolism","volume":"14","author":"Dong","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2021.112080_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jpba.2012.03.051","article-title":"Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry","volume":"70","author":"Tong","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2021.112080_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jchromb.2016.03.030","article-title":"An LC-MS\/MS method for simultaneous determination of four flavonoids from Semen Oroxyli in rat plasma and its application to a pharmacokinetic study","volume":"1020","author":"Zhang","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.biopha.2021.112080_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2012.07.010","article-title":"Simultaneous determination of active flavonoids and alkaloids of Tang-Min-Ling-Pill in rat plasma by liquid chromatography tandem mass spectrometry","volume":"904","author":"Zhu","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.biopha.2021.112080_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112874","article-title":"Comparative pharmacokinetic study of the components in Alpinia oxyphylla Miq.-Schisandra chinensis (Turcz.) Baill. herb pair and its single herb between normal and Alzheimer\u2019s disease rats by UPLC-MS\/MS","volume":"177","author":"Qi","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.biopha.2021.112080_bib42","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3109\/21691401.2015.1029633","article-title":"Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line","volume":"44","author":"Anari","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.biopha.2021.112080_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120044","article-title":"Chrysin nanocapsules with dual anti-glycemic and anti-hyperlipidemic effects: chemometric optimization, physicochemical characterization and pharmacodynamic assessment","volume":"592","author":"El-Hussien","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112080_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112696","article-title":"Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by \u03b2-amyloid1-42 in aged female mice","volume":"390","author":"Giacomeli","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"8","key":"10.1016\/j.biopha.2021.112080_bib45","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1039\/C9FO01142K","article-title":"Effect of chrysin on changes in intestinal environment and microbiome induced by fructose-feeding in rats","volume":"10","author":"Andrade","year":"2019","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.biopha.2021.112080_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/03602532.2017.1293682","article-title":"Glucuronidation: driving factors and their impact on glucuronide disposition","volume":"49","author":"Yang","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.biopha.2021.112080_bib47","first-page":"501","article-title":"The enterohepatic circulation of bile acids in man","volume":"21","author":"Hofmann","year":"1976","journal-title":"Adv. Intern Med"},{"issue":"1","key":"10.1016\/j.biopha.2021.112080_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13318-014-0234-5","article-title":"Evaluation of physicochemical properties and intestinal permeability of six dietary polyphenols in human intestinal colon adenocarcinoma Caco-2 cells","volume":"41","author":"Rastogi","year":"2016","journal-title":"Eur. J. Drug Metab. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2021.112080_bib49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharm. Toxicol. Methods"},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.112080_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2021.112080_bib51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Disco Today Technol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112080_bib52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-2952(99)00133-1","article-title":"Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2","volume":"58","author":"Walle","year":"1999","journal-title":"Biochem. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2021.112080_bib53","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2021.112080_bib54","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1021\/jf5056979","article-title":"Determination of pharmacokinetics of chrysin and its conjugates in wild-type FVB and Bcrp1 knockout mice using a validated LC-MS\/MS method","volume":"63","author":"Ge","year":"2015","journal-title":"J. Agric. Food Chem."},{"issue":"16","key":"10.1016\/j.biopha.2021.112080_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ma13163618","article-title":"Cyclodextrin complexation improves the solubility and Caco-2 permeability of chrysin","volume":"13","author":"Fenyvesi","year":"2020","journal-title":"Materials (Basel)"},{"issue":"3","key":"10.1016\/j.biopha.2021.112080_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030760","article-title":"Chrysin modulates genes related to inflammation, tissue remodeling, and cell proliferation in the gastric ulcer healing","volume":"21","author":"Fagundes","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.112080_bib57","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.toxlet.2015.01.008","article-title":"Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives","volume":"233","author":"Kasala","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2021.112080_bib58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.phrs.2017.05.001","article-title":"UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: a systematic review of UGT isoforms for precision medicine","volume":"121","author":"Yang","year":"2017","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.112080_bib59","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/mnfr.201500692","article-title":"Disposition of flavonoids via recycling: direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides","volume":"60","author":"Zeng","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.112080_bib60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/dmd.114.061598","article-title":"Characterization of chrysin glucuronidation in UGT1A1-overexpressing HeLa cells: elucidating the transporters responsible for efflux of glucuronide","volume":"43","author":"Quan","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.biopha.2021.112080_bib61","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/jf304853j","article-title":"Identification of flavone glucuronide isomers by metal complexation and tandem mass spectrometry: regioselectivity of uridine 5\u2032-diphosphate-glucuronosyltransferase isozymes in the biotransformation of flavones","volume":"61","author":"Robotham","year":"2013","journal-title":"J. Agric. Food Chem."},{"issue":"12","key":"10.1016\/j.biopha.2021.112080_bib62","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1080\/004982599237912","article-title":"Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells","volume":"29","author":"Galijatovic","year":"1999","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.biopha.2021.112080_bib63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bcp.2015.08.090","article-title":"Efflux transport of chrysin and apigenin sulfates in HEK293 cells overexpressing SULT1A3: the role of multidrug resistance-associated protein 4 (MRP4\/ABCC4)","volume":"98","author":"Li","year":"2015","journal-title":"Biochem. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2021.112080_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080370","article-title":"Pharmacokinetics of B-ring unsubstituted flavones","volume":"11","author":"Ancuceanu","year":"2019","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.biopha.2021.112080_bib65","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1021\/acs.chemrestox.9b00078","article-title":"Oxidation of flavone, 5-hydroxyflavone, and 5,7-dihydroxyflavone to mono-, di-, and tri-hydroxyflavones by human cytochrome p450 enzymes","volume":"32","author":"Nagayoshi","year":"2019","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112080_bib66","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/09168451.2018.1444467","article-title":"Flavonoid metabolism: the interaction of metabolites and gut microbiota","volume":"82","author":"Murota","year":"2018","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"6","key":"10.1016\/j.biopha.2021.112080_bib67","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2174\/138955710791384081","article-title":"Bioavailability challenges associated with development of anti-cancer phenolics","volume":"10","author":"Gao","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2021.112080_bib68","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/bj1280901","article-title":"Metabolism of apigenin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro","volume":"128","author":"Griffiths","year":"1972","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.biopha.2021.112080_bib69","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1021\/jf0500177","article-title":"Human gut microbial degradation of flavonoids: structure-function relationships","volume":"53","author":"Simons","year":"2005","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.biopha.2021.112080_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport--an update","volume":"17","author":"Mao","year":"2015","journal-title":"Aaps J."},{"issue":"3","key":"10.1016\/j.biopha.2021.112080_bib71","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"International Transporter","year":"2010","journal-title":"Nat. Rev. Drug Disco"},{"issue":"1","key":"10.1016\/j.biopha.2021.112080_bib72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1007506222436","article-title":"Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells","volume":"17","author":"Galijatovic","year":"2000","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.112080_bib73","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1023\/A:1011019417236","article-title":"Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells--potential role in carcinogen bioinactivation","volume":"18","author":"Galijatovic","year":"2001","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.biopha.2021.112080_bib74","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0090-9556(24)15189-6","article-title":"Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2","volume":"28","author":"Walle","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.biopha.2021.112080_bib75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.21481","article-title":"The role of chrysin and the ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice","volume":"45","author":"Bonzo","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2021.112080_bib76","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/jpet.105.090795","article-title":"Differential UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 Cells","volume":"315","author":"Smith","year":"2005","journal-title":"J. Pharm. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2021.112080_bib77","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1124\/mol.65.5.1208","article-title":"Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport","volume":"65","author":"Zhang","year":"2004","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2021.112080_bib78","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/dmd.120.000085","article-title":"Effects of chrysin and its major conjugated metabolites chrysin-7-sulfate and chrysin-7-glucuronide on cytochrome p450 enzymes and on OATP, P-gp, BCRP, and MRP2 transporters","volume":"48","author":"Mohos","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2021.112080_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104642","article-title":"Evaluation of inhibitory effects of flavonoids on breast cancer resistance protein (BCRP): From library screening to biological evaluation to structure-activity relationship","volume":"61","author":"Fan","year":"2019","journal-title":"Toxicol. Vitr."},{"issue":"6","key":"10.1016\/j.biopha.2021.112080_bib80","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1124\/dmd.108.025064","article-title":"Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrier","volume":"37","author":"Zhao","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.biopha.2021.112080_bib81","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/dmd.104.002501","article-title":"Flavonoids chrysin and benzoflavone, potent breast cancer resistance protein inhibitors, have no significant effect on topotecan pharmacokinetics in rats or mdr1a\/1b (-\/-) mice","volume":"33","author":"Zhang","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.biopha.2021.112080_bib82","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1567201815666180924151458","article-title":"Improved in vivo effect of chrysin as an absorption enhancer via the preparation of ternary solid dispersion with Brij(R)L4 and aminoclay","volume":"16","author":"Lee","year":"2019","journal-title":"Curr. Drug Deliv."},{"issue":"6","key":"10.1016\/j.biopha.2021.112080_bib83","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.bcp.2007.11.012","article-title":"Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes","volume":"75","author":"Quintieri","year":"2008","journal-title":"Biochem Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2021.112080_bib84","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/BF02972971","article-title":"Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes","volume":"28","author":"Kim","year":"2005","journal-title":"Arch. Pharm. Res."},{"issue":"7","key":"10.1016\/j.biopha.2021.112080_bib85","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/00498254.2017.1358469","article-title":"Honey flavonoids inhibit hOATP2B1 and hOATP1A2 transporters and hOATP-mediated rosuvastatin cell uptake in vitro","volume":"48","author":"Navratilova","year":"2018","journal-title":"Xenobiotica"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:59:06Z","timestamp":1778543946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221008635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":85,"alternative-id":["S0753332221008635"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112080","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing nutritional component chrysin as a therapeutic agent: Bioavailability and pharmacokinetics consideration, and ADME mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112080"}}